Dosing & Uses
Dosage Forms & Strengths
injectable solution
- 200mg/mL
Lead Chelation
Asymptomatic, blood lead 20-70 mcg/dL
- 1 g/sq.meter IV/IM
Symptoms of lead encephalopathy and/or blood lead level >70 mcg/dL
- Use with dimercaprol (BAL) x5 days
- IV: 50 mg/kg/day infused over 24 hours, OR 1 g/sq.meter infused over 8-24 hours
- IM: 250 mg/sq.meter/dose q4hr
- After 5-day therapy completed, wait at least 2 days before deciding to repeat regimen
Lead nephropathy
- 500 mg/sq.meter IV/IM q24hr x5 days
- Serum Cr 3-4 mg/dL: 500 mg/sq.meter IV/IM q48hr x3 doses
- Serum Cr >4 mg/dL: 500 mg/sq.meter IV/IM qWeek
- May repeat above regimens at 1 month intervals
Other Indications & Uses
Lead poisoning
Lead encephalopathy must be treated with combination BAL preceeding CaNa2EDTA
May be useful for zinc and manganese poisoning & certain heavy radioisotopes
Dosage Forms & Strengths
injectable solution
- 200mg/mL
Lead Chelation
Asymptomatic, blood lead 20-70 mcg/dL
- 1 g/sq.meter IV/IM
Symptoms of lead encephalopathy and/or blood lead level >70 mcg/dL
- Use with dimercaprol (BAL) x5 days
- IV: 50 mg/kg/day infused over 24 hours, OR 1 g/sq.meter infused over 8-24 hours
- IM: 250 mg/sq.meter/dose q4hr
- After 5-day therapy completed, wait at least 2 days before deciding to repeat regimen
Adverse Effects
Frequency Not Defined
Renal tubular necrosis
Pain at site
Anorexia
Nausea/vomiting
Cheilosis
Hypercalcemia
Zinc depletion
Dysrhythmias
Inverted T-waves
Bone marrow depression
Anemia
Incr prothrombin times
Malaise
Fatigue
Fever
Chills
Histamine response
Excessive thirst
Warnings
Black Box Warnings
Edetate calcium disodium is capable of producing toxic effects, which can be fatal. Lead encephalopathy is relatively rare in adults but occurs more often in children in whom it may be incipient and thus overlooked. The mortality rate in children has been high. Patients with lead encephalopathy and cerebral edema may experience a lethal increase in intracranial pressure following intravenous infusion. The intramuscular route is preferred for these patients. In cases where the intravenous route is necessary, avoid rapid infusion. The dosage schedule should be followed, and at no time should the recommended daily dose be exceeded.
Cautions
Oliguria: discontinue if renal failure occurs (dosage adjustment if reduced creatinine clearance)
Pain occurs at inj site
Do NOT use disodium edetate (Na2H2EDTA) for heavy metal toxicity
- may cause hypocalcemia-related tetany & even death
Pregnancy & Lactation
Pregnancy Category: B
Lactation: excretion in milk unknown; use with caution
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Mechanism of Action
Chelating agent to enhance elimination of metals, particulary lead
Agent being chelated takes place of Ca++
Administration
Use IM in children and pts at risk for lead encephalopathy (may be lethal IV)
Use 1 mL 1% procaine soln, for each mL chelator to minimize pain at injection site
IV: dilute in 250-500 mL NS or D5W with infusion over 1 hr, if asymptomatic
Symptomatic adults require intermittent IV infusion preferably over 12-24 hr, 4 hr after BAL
Monitor renal function closely
Keep pt well hydrated, adequate urine output
Dialysis will remove chelate if pt has renal failure
Images
Patient Handout
edetate calcium disodium injection
NO MONOGRAPH AVAILABLE AT THIS TIME
USES: Consult your pharmacist.
HOW TO USE: Consult your pharmacist.
SIDE EFFECTS: Consult your pharmacist.In the US -Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
PRECAUTIONS: Consult your pharmacist.
DRUG INTERACTIONS: Consult your pharmacist.Keep a list of all your medications with you, and share the list with your doctor and pharmacist.
OVERDOSE: If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.
NOTES: No monograph available at this time.
MISSED DOSE: Consult your pharmacist.
STORAGE: Consult your pharmacist.Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.
Information last revised July 2016. Copyright(c) 2023 First Databank, Inc.
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
Formulary
Adding plans allows you to compare formulary status to other drugs in the same class.
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.
